The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

Source:http://linkedlifedata.com/resource/pubmed/id/9123736

Download in:

View as

General Info

PMID
9123736